CLRBZ
Cellectar Biosciences, Inc. Series A Warrants
CLRBZ
CLRBZ
Delisted
CLRBZ was delisted on the 16th of April, 2021.
2 hedge funds and large institutions have $9K invested in Cellectar Biosciences, Inc. Series A Warrants in 2021 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2
Holders Change
-1
Holders Change %
-33.33%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
VF
1
Virtu Financial
New York
|
$8K |
Top Sellers
| 1 |
ACM
1
AIGH Capital Management
Baltimore,
Maryland
|
$0 |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$1K |
| 3 |
TSS
3
Two Sigma Securities
New York
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
VF
1
Virtu Financial
New York
| $8K | +$8K | +21,755 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $1K | -$17.6K | -28,027 | -95% |
|
|
ACM
3
AIGH Capital Management
Baltimore,
Maryland
| – | -$1.23M | -583,037 | Closed |
|
|
TSS
4
Two Sigma Securities
New York
| – | -$2K | -14,221 | Closed |
|